|
RUNX2 supports oncogenic phenotypes in PAX3::FOXO1 fusion-positive rhabdomyosarcoma; Enhancing NK tumor killing by antibodies against HLA-E |
07/31/2024 - 8:00am to 9:00am EDT |
|
Advancing Patient Care: Updates on CHG+ Integration and Addressing Barriers in Cellular Therapy; Optimal Perioperative Management of Localized Esophageal Cancer |
08/07/2024 - 8:00am to 9:00am EDT |
|
Tumor Infiltrating Lymphocytes Across Breast Cancer Subtypes / SPOP alterations in metastatic prostate cancer |
08/14/2024 - 8:00am to 9:00am EDT |
|
Toward Manipulating Sex Hormones to Modulate the Adaptive Antitumor Immune Response in Liver Cancer; Role of Snord67 in breast cancer lymphatic metastasis |
08/21/2024 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2024 |
08/28/2024 - 8:00am to 9:00am EDT |
|
Current Issues in Health Care Reform and Cancer Care |
09/04/2024 - 8:00am to 9:00am EDT |
|
A Hematologic Presentation of Metastatic Carcinoma / Expanding access to molecular profiling with new approaches to circulating tumor DNA sequencing |
09/11/2024 - 8:00am to 9:00am EDT |
|
Hematology Overview / Basic Research in Hematology / Clinical Research in Hematology |
09/18/2024 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2024 |
09/25/2024 - 8:00am to 9:00am EDT |
|
Malignant Heme/Cell Therapy Division Updates Part 1 |
10/02/2024 - 8:00am to 9:00am EDT |
Facebook
Twitter
LinkedIn
Forward